islatravir/lenacapavir

From Aaushi
Jump to navigation Jump to search
[1]

Indications

More general terms

Components

References

  1. ↑ 1.0 1.1 Colson AE, Crofoot GE, Ruane PJ et al Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 : A Phase 2 Randomized Study. Ann Intern Med. 2025 Dec 23. PMID: https://pubmed.ncbi.nlm.nih.gov/41429026
Retrieved from "https://aaushi.info/w/index.php?title=A59451&oldid=1283146"